Mutual of America Capital Management LLC Sells 1,703 Shares of Progyny, Inc. (NASDAQ:PGNY)

Mutual of America Capital Management LLC lessened its stake in Progyny, Inc. (NASDAQ:PGNY) by 3.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 49,681 shares of the company’s stock after selling 1,703 shares during the period. Mutual of America Capital Management LLC’s holdings in Progyny were worth $1,895,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of PGNY. Teachers Retirement System of The State of Kentucky lifted its stake in shares of Progyny by 100.3% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 25,208 shares of the company’s stock valued at $858,000 after acquiring an additional 12,620 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Progyny by 7.4% in the 3rd quarter. Vanguard Group Inc. now owns 8,157,604 shares of the company’s stock valued at $277,522,000 after acquiring an additional 565,160 shares during the last quarter. RiverPark Advisors LLC raised its position in Progyny by 54.0% during the 4th quarter. RiverPark Advisors LLC now owns 1,067 shares of the company’s stock valued at $40,000 after purchasing an additional 374 shares during the last quarter. Pacer Advisors Inc. raised its position in Progyny by 148.7% during the 4th quarter. Pacer Advisors Inc. now owns 17,254 shares of the company’s stock valued at $642,000 after purchasing an additional 10,317 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH raised its position in Progyny by 58.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 688,020 shares of the company’s stock valued at $25,581,000 after purchasing an additional 252,910 shares during the last quarter. Institutional investors own 94.93% of the company’s stock.

Analyst Ratings Changes

PGNY has been the subject of a number of recent analyst reports. Canaccord Genuity Group lowered their price target on Progyny from $46.00 to $37.00 and set a “buy” rating for the company in a research report on Friday, May 10th. Cantor Fitzgerald reissued an “overweight” rating and issued a $48.00 target price on shares of Progyny in a research report on Thursday, May 16th. Barclays decreased their target price on Progyny from $48.00 to $30.00 and set an “overweight” rating for the company in a research report on Monday, May 13th. KeyCorp lowered Progyny from an “overweight” rating to a “sector weight” rating in a research report on Friday, May 10th. Finally, BTIG Research decreased their target price on Progyny from $50.00 to $41.00 and set a “buy” rating for the company in a research report on Friday, May 10th. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $43.11.

Insider Buying and Selling at Progyny

In other Progyny news, President Michael E. Sturmer sold 4,515 shares of the stock in a transaction on Wednesday, May 1st. The stock was sold at an average price of $31.95, for a total transaction of $144,254.25. Following the sale, the president now directly owns 380,038 shares in the company, valued at approximately $12,142,214.10. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Progyny news, President Michael E. Sturmer sold 4,515 shares of the stock in a transaction on Wednesday, May 1st. The stock was sold at an average price of $31.95, for a total transaction of $144,254.25. Following the sale, the president now directly owns 380,038 shares in the company, valued at approximately $12,142,214.10. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Cheryl Scott sold 1,462 shares of the stock in a transaction on Friday, June 28th. The shares were sold at an average price of $28.39, for a total value of $41,506.18. Following the sale, the director now owns 10,098 shares in the company, valued at $286,682.22. The disclosure for this sale can be found here. Company insiders own 12.30% of the company’s stock.

Progyny Stock Up 2.7 %

Progyny stock opened at $28.95 on Friday. The company has a market capitalization of $2.76 billion, a P/E ratio of 47.46, a PEG ratio of 1.88 and a beta of 1.46. The stock’s 50 day moving average is $27.80 and its 200 day moving average is $33.61. Progyny, Inc. has a twelve month low of $23.90 and a twelve month high of $44.95.

Progyny (NASDAQ:PGNY) last issued its earnings results on Thursday, May 9th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.14 by $0.03. Progyny had a return on equity of 11.61% and a net margin of 5.53%. The business had revenue of $278.08 million for the quarter, compared to the consensus estimate of $289.41 million. During the same period last year, the business posted $0.18 EPS. The company’s revenue was up 7.6% compared to the same quarter last year. As a group, equities analysts expect that Progyny, Inc. will post 0.73 EPS for the current year.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.